Logo image of CLE.MI

CLASS EDITORI SPA (CLE.MI) Stock Fundamental Analysis

BIT:CLE - Euronext Milan - IT0005117848 - Common Stock - Currency: EUR

0.128  -0.01 (-4.48%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLE. CLE was compared to 63 industry peers in the Media industry. Both the profitability and financial health of CLE have multiple concerns. CLE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLE has reported negative net income.
CLE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLE reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CLE reported negative operating cash flow in multiple years.
CLE.MI Yearly Net Income VS EBIT VS OCF VS FCFCLE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

With a Return On Assets value of -1.75%, CLE is not doing good in the industry: 73.02% of the companies in the same industry are doing better.
With a Return On Equity value of -33.80%, CLE is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 1.95%, CLE is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CLE had an Average Return On Invested Capital over the past 3 years of 10.13%. This is in line with the industry average of 8.31%.
The last Return On Invested Capital (1.95%) for CLE is well below the 3 year average (10.13%), which needs to be investigated, but indicates that CLE had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.75%
ROE -33.8%
ROIC 1.95%
ROA(3y)2.82%
ROA(5y)-1.7%
ROE(3y)44.72%
ROE(5y)N/A
ROIC(3y)10.13%
ROIC(5y)N/A
CLE.MI Yearly ROA, ROE, ROICCLE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

CLE has a Operating Margin of 3.14%. This is in the lower half of the industry: CLE underperforms 60.32% of its industry peers.
Looking at the Gross Margin, with a value of 69.96%, CLE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CLE has grown nicely.
Industry RankSector Rank
OM 3.14%
PM (TTM) N/A
GM 69.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y2.46%
CLE.MI Yearly Profit, Operating, Gross MarginsCLE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

CLE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CLE remains at a similar level compared to 1 year ago.
CLE has more shares outstanding than it did 5 years ago.
CLE has a worse debt/assets ratio than last year.
CLE.MI Yearly Shares OutstandingCLE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLE.MI Yearly Total Debt VS Total AssetsCLE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

CLE has an Altman-Z score of -0.52. This is a bad value and indicates that CLE is not financially healthy and even has some risk of bankruptcy.
CLE's Altman-Z score of -0.52 is on the low side compared to the rest of the industry. CLE is outperformed by 79.37% of its industry peers.
CLE has a Debt/Equity ratio of 4.41. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CLE (4.41) is worse than 87.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.41
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACC0.34
WACC5.7%
CLE.MI Yearly LT Debt VS Equity VS FCFCLE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.72 indicates that CLE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, CLE is doing worse than 77.78% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that CLE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, CLE is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.7
CLE.MI Yearly Current Assets VS Current LiabilitesCLE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

CLE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -381.08%.
The Revenue has decreased by -0.71% in the past year.
Measured over the past years, CLE shows a small growth in Revenue. The Revenue has been growing by 0.70% on average per year.
EPS 1Y (TTM)-381.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.73%
Revenue 1Y (TTM)-0.71%
Revenue growth 3Y5.52%
Revenue growth 5Y0.7%
Sales Q2Q%1.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLE.MI Yearly Revenue VS EstimatesCLE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CLE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLE.MI Price Earnings VS Forward Price EarningsCLE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLE indicates a slightly more expensive valuation: CLE is more expensive than 60.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.44
CLE.MI Per share dataCLE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLASS EDITORI SPA

BIT:CLE (8/1/2025, 1:21:36 PM)

0.128

-0.01 (-4.48%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners63.96%
Ins Owner ChangeN/A
Market Cap41.31M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 4.84
P/tB N/A
EV/EBITDA 7.44
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.24
BVpS0.03
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.75%
ROE -33.8%
ROCE 3.24%
ROIC 1.95%
ROICexc 2.05%
ROICexgc 19.41%
OM 3.14%
PM (TTM) N/A
GM 69.96%
FCFM N/A
ROA(3y)2.82%
ROA(5y)-1.7%
ROE(3y)44.72%
ROE(5y)N/A
ROIC(3y)10.13%
ROIC(5y)N/A
ROICexc(3y)10.66%
ROICexc(5y)N/A
ROICexgc(3y)81.76%
ROICexgc(5y)N/A
ROCE(3y)15.71%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y2.46%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 4.41
Debt/FCF N/A
Debt/EBITDA 3.92
Cap/Depr 71.96%
Cap/Sales 6.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.7
Altman-Z -0.52
F-Score3
WACC5.7%
ROIC/WACC0.34
Cap/Depr(3y)66.6%
Cap/Depr(5y)71.2%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.71%
Revenue growth 3Y5.52%
Revenue growth 5Y0.7%
Sales Q2Q%1.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-318.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-209.58%
OCF growth 3YN/A
OCF growth 5YN/A